Epilepsy: open trials in Netherlands

14 open trials have a site in Netherlands. Registry data; only the trial team decides who can take part.

NCT05667142
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
Trial Treatment · Phase 3 · Xenon Pharmaceuticals Inc.
Kempenhaeghe, Heeze
Registry updated 2026-11-02
NCT05716100
A Randomized Study of XEN1101 Versus Placebo in Focal-Onset Seizures (X-TOLE3)
Trial Treatment · Phase 3 · Xenon Pharmaceuticals Inc.
Kempenhaeghe, Heeze
Registry updated 2026-11-02
NCT05718817
An Open-label Study of XEN1101 in Epilepsy
Trial Treatment · Phase 3 · Xenon Pharmaceuticals Inc.
Kempenhaeghe, Heeze
Registry updated 2026-11-02
NCT06908226
A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathy (DEE)
Trial Treatment · Phase 3 · Longboard Pharmaceuticals
Universitair Medisch Centrum Utrecht - Polikliniek Oogheelkunde, Utrecht
Registry updated 2026-10-14
NCT06443463
A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy
Trial Treatment · Phase 2 · Biohaven Therapeutics Ltd.
Epilepsie Instellingen Nederland Stichting, Heemstede · Kempenhaeghe, Heeze · Epilepsie Instellingen Nederland Stichting, Zwolle
Registry updated 2026-09-28
2026-527114-23-00
OV329 Evaluation in Participants with Epilepsy and PPR
Trial Treatment · Phase 2 · Ovid Therapeutics Inc.
Centre for Human Drug Research, Leiden
Registry updated 2026-09-15
NCT07775872
Prospective Natural History Study of POLG Disease
Research · The POLG Foundation
Maastricht University-Maastricht, Maastricht
Registry updated 2026-09-15
2025-524019-35-00
Three-part PK and PD study of AXN-027
Trial Treatment · Phase 1 · Axonis Therapeutics Inc.
Centre for Human Drug Research, Leiden
Registry updated 2026-09-04
2026-525896-23-00
A Double-blind, Placebo-controlled Study to Evaluate the Safety, Tolerability, and Potential Antiseizure Activity of Adjunctive OV329 Therapy in Adults with Drug-Resistant Focal Epilepsy
Trial Treatment · Phase 2 · Ovid Therapeutics Inc.
Academisch Ziekenhuis Maastricht, Maastricht
Registry updated 2026-08-21
NCT07668856
Cannabidiol as add-on Therapy for Children With Refractory Epilepsy (CBD-uN1que), a High-quality Individualized Approach: a Series of N-of-1 Trials
Trial Treatment · Phase 3 · UMC Utrecht
University Medical Center Utrecht, Utrecht
Registry updated 2026-06-25
2025-524134-26-00
Effect of NBI-921355 on corticospinal excitability in healthy participants
Trial Treatment · Phase 1 · Neurocrine Biosciences Inc.
Centre for Human Drug Research, Leiden
Registry updated 2026-05-04
2023-507843-12-01
Cannabidiol in refractory childhood epilepsy, a personalized high-quality approach
Trial Treatment · Phase 3 · Universitair Medisch Centrum Utrecht
Epilepsy Instellingen Nederland Stichting, Heemstede · Kempenhaeghe, Heeze · University Hospital Maastricht, Maastricht · Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC), Rotterdam · Universitair Medisch Centrum Utrecht, Utrecht
Registry updated 2025-12-31
NCT06205160
Evaluation of New Flexible High-density Intra-operative ECoG Electrodes for Epilepsy Surgery. ( EpiGrid )
Trial Treatment · Neurosoft Bioelectronics SA
University Medical Center (UMC) Utrecht, Utrecht
Registry updated 2025-12-10
NCT06922175
REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization
Research · Aziende Chimiche Riunite Angelini Francesco S.p.A
Kempenhaeghe - Academisch Centrum voor Epilepsie, Heeze
Registry updated 2025-10-02

All Epilepsy trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error